Jonathan Rochon, Pier-Luc Plante, Serge Auger, Réal Paquin, Jacques Corbeil, Pierre Picard

Similar documents
LCMS-8050 Drugs of Abuse: 113 Analytes with Polarity Switching

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D Director: David J.

Automated Targeted screening of Benzodiazepines in urine using LDTD-MS/MS at 400 samples per hour rate

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years

Fully Automated Online Sample Preparation and LC-MS/MS Analysis of Drugs of Abuse in Oral Fluids

1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia

Forensic Toxicology Scope of Testing and Detection Limits

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years

Rapid and Sensitive Analysis of a 93-Compound Forensic Panel in Urine using the QTRAP /Triple Quad 4500 LC- MS/MS System

Alcohol. Ethanol Highlands Parkway, Suite 100 Smyrna, GA 30082

Validation of an Automated Method to Remove

[ APPLICATION NOTE ] APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS

Validation of a Benzodiazepine and Z-Drug Method Using an Agilent 6430 LC/MS/MS

Pain Management and Compliance Toxicology. Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX

nextgen precision Test Report

A Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography

Validation Report for the Neogen Fentanyl Kit for ELISA Screening of Whole Blood and Urine Specimens

Drug Adherence Assessment Report

Rapid LC/TOF MS for Analytical Screening of Drugs in the Clinical Research Lab

Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population

INTERPATH LABORATORY, INC. TEST UPDATES

The Drug Testing Process. Employer or Practice

Ultra-Fast Forensic Toxicological Screening and Quantitation under 3 Minutes using SCIEX X500R QTOF System and SCIEX OS 1.

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY

LC Application Note. Dangerous driver?

September HCMC Toxicology Transition: Additional information and Frequently Asked Questions

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY

May Revised Urine Drug Screen Test Menu Effective mid-june Lauren Anthony, MD, MT(ASCP) SBB Medical Director, Allina Health Laboratory

Drugs of Abuse I Serum

E XCEL LENCE JUST GOT BETTER UCT FORENSICS CLEAN SCREEN XCEL SPE COLUMNS

Proof of Concept for Automated SPE/HPLC/MS/MS Methods to Replace Traditional Immunoassay with MS Confirmation of Driving Under the Influence Samples

CDIA TM Marijuana Colloidal Gold Test Cassette (Saliva)

Drug Adherence Assessment Report

Toxicology Practice and Procedure Handbook

Agilent Clinical LC/MS: Review of Established LC-MS QQQ Clinical Research Applications. dr. Jan Srbek, HPST. Page 1

Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations. Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K.

Physician s Reference for Urine and Blood Drug Testing and Interpretation

Drugs of Abuse in Oral Fluids: Automated SPE Extraction and LC/MS/MS Determination using a Robotic Autosampler

Comparison of Different Whole Blood Sample Pretreatment Methods for Targeted Analysis of Basic Drugs

Offline and online sample extraction for the quantification of benzodiazepines in human plasma or serum for clinical research

DrugSmartCup & DrugSmartDip Accuracy Report as produced by Ameditech, Inc.

A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS

Test Definition: PCDSO Pain Clinic Drug Screen, Urine

Drugs Found in Medical Examiner Cases

Test Definition: PDSOX Pain Clinic Drug Screen, Chain of Custody, Urine

METHAMPHETAMINE & AMPHETAMINE

Urine Opioid Dependency Panel (UODP) 1

Determination of 78 Banned or Controlled Racing Industry Drugs in Horse Urine Using SPE and LC-MS/MS

ChemaTox Blood Drug Testing Matrix (Updated May 24th, 2016)

Application Note LCMS-108 Quantitation of benzodiazepines and Z-drugs in serum with the EVOQ TM LC triple quadrupole mass spectrometer

Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization

Lyndsey Knoy, D-ABFT-FT Forensic Scientist Washington State Toxicology Laboratory.

Rapid Biofluid Analysis using the Prosolia Velox 360 PaperSpray System and Mass Spectrometry

10/9/18. Learning Objectives. Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization

ORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS

High-Throughput Quantitative LC-MS/MS Analysis of 6 Opiates and 14 Benzodiazepines in Urine

4.5 Minute Analysis of Benzodiazepines in Urine and Whole Blood Using LC/MS/MS and an Ultra Biphenyl Column

Urine Drug Testing Methods 3-5

2015 Annual Physician Notice

APPLICATION TN Rapid Analysis of a 48 Drug Research Panel in Less Than 4 Minutes Using Kinetex Biphenyl Core-Shell Technology HPLC/UHPLC Columns

LABORATORY TECHNICAL SPECIFICATIONS MANUAL

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Laboratory Service Report

Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies

Centre of Forensic Sciences

NEW. Kinetex. Biphenyl TMS TMS TMS TMS. Selectivity that a C18 just can t give you!

Prescription Drug Monitoring Reference Guide: 2017

Evaluation of an LC-MS/MS Research Method for the Analysis of 33 Benzodiazepines and their Metabolites

Opiates, Opioids and Benzodiazepines, Amphetamines & Illicit Drug Forensic Analysis by LC/MS

Alcohol Biomarkers by UHPLC-MS/MS

DOF. Scheme Description. Drugs in Oral Fluid Scheme

LABORATORY TECHNICAL SPECIFICATIONS MANUAL

LABORATORY TECHNICAL SPECIFICATIONS MANUAL

LC-MS/MS Method for the Determination of 21 Opiates and Opiate Derivatives in Urine

A Rapid Method for Detection of Drugs of Abuse in Blood Samples Using the Thermal Separation Probe and the 5975T LTM GC/MS

01/01/ years INCONSISTENT RESULTS - REPORTED MEDICATION NOT DETECTED (NEITHER PARENT DRUG NOR METABOLITE) REPORTED PRESCRIPTION

1. Amphetamine (Adderall, desoxyn, Dexedrine,dextrostat, spancap, oxydess II)

New Test Announcements

ALAMEDA COUNTY BEHAVIORAL HEALTH CARE SERVICES MEDICATION FORMULARY

C O P E. Milwaukee County Opioid-Related Overdose Report MILWAUKEE COMMUNITY OPIOID PREVENTION EFFORT

Powerful Sample Prep and LC Column Solutions for Forensic Toxicology Applications

Comparison of the Stability of Stock Solutions of Drugs of Abuse and Other Drugs Stored in a Freezer, Refrigerator, and at Ambient Temperature

APPLICATIONS TN Analytical Method

Overview. Introduction. Experimental. Cliquid Software for Routine LC/MS/MS Analysis

Toxicological Investigation of Drug Impaired Driving Toxicology Laboratory Survey

Prepared by Date Adopted Supersedes Procedure # Review Date Revision Date Signature. Distributed to # of Copies Distributed to # of Copies

Achieving Proposed Federal Concentrations using Reduced Specimen Volume for the Extraction of Amphetamines from Oral Fluid

PAIN PANEL. Research and Solutions

T2007 Seattle, Washington

Detection of Neonatal Drug Exposure Using Umbilical Cord Tissue and Liquid Chromatography Time-of-Flight Mass Spectrometry

Your Results are Our Priority.

Rapid screening and semi-quantitative analysis for forensic drugs in blood using liquid chromatography triple quadrupole mass spectrometry

Multi-Drug Screen Test

European Guidelines for Workplace Drug Testing in Blood and Blood Spots

Welcome - SAMHSA s Role. Welcome SAMHSA Key Messages 4. Welcome SAMHSA s Direction

PROFILE -V MEDTOXScan Drugs of Abuse Test System INSERT

Drugs, Sleep & Wakefulness. Brian Koo Reena Mehra MD MS Kingman Strohl MD

European Guidelines for Workplace Drug Testing in UrineandOral fluid

Pain Medication Management Program Supports Patient Outcomes and Adherence

ToxCup Drug Screen Cup Step-by Step Instructions

Transcription:

Dried Blood Spots in Tips Targeted Drug Screening in 9 Seconds per Sample Using Laser Diode Thermal Desorption Mass Spectrometry (LDTD-MS/MS) Jonathan Rochon, Pier-Luc Plante, Serge Auger, Réal Paquin, Jacques Corbeil, Pierre Picard

Introduction Dried blood spot technique is widely used in blood collection for clinical or medical analysis. High-throughput mass spectrometry is used to analyze a sample in seconds. Combination of Dried Blood Spot and High-throughput mass spectrometry could save time and lower the cost for targeted screening approach.

Dried Blood Spots Advantages: Challenges: Quick and simple collection of blood sample. Stability when the sample is dried. Low level training to collect sample. Whole blood analysis results on higher background. Efficiency of extraction. Low sensitivity due to small sample volume. Hematocrit induces variability in sample volume analyzed.

DBS in Tips Fiber material contained in a standard 200 µl tip. Drying and extraction is done directly in the tip. No need for further manipulation of the fiber. Advantages: No Hematocrit effect since the whole blood volume is contained in the fiber. Requires only 2 µl of blood.

Objective Objective: Evaluate the DBS in Tips technique with a wide selection of drug compounds (122) with a screening approach. Drugs panel: Amphetamines, Barbiturates, Opioids, Benzodiazepines, Selective serotonin reuptake inhibitors (SSRI), Serotonin-norepinephrine reuptake inhibitors (SNRI), Tetracyclic antidepressants, Carbamates, Cannabinoids and others. Experimental: Drug panel is separated in 7 groups and analyzed with 7 deuterated internal standards with a LDTD - Sciex Q-Trap 5500 MS/MS system. The LDTD ion source is used to monitor all 122 transitions in 9 seconds.

Method - Blood Sampling 1) 2 µl of water mixed with the group of IS are deposited on the fiber to pre-wet it. 2) 2 µl of blank blood or of spiked blood at 25, 50 and 100 ng/ml are deposited on the fiber. 3) 8 replicates for each concentration, a double blank and a blank are prepared. 4) The blood is dried for at least 12 hrs. Dried for > 12 hrs. Wet Blood Dry Blood

Method Pre-wetting the fiber ensures an efficient extraction. Area: 1.080e 5 Cotinine desorption peak from pre-wet fiber Area: 2.884e 3 Cotinine desorption peak from dry fiber

Method - Extraction 1) 24 µl of a solution of MeOH:H 2 O (90/10, v/v) are aspirated in the tips with an automatic pipette. 2) 16 µl of air gap to allow all the MeOH:H 2 O to penetrate the fiber. 3) Wait 10 seconds. 4) Deposit the whole volume on EDTA coated Lazwell TM 96HDE plate (~ 10 µl).

Extraction solution The MeOH:H 2 O ratio in the extraction solution is optimized to maximize the final volume extracted and lower the S/N ratio without extracting the red blood cells. 90:10 70:30 50:50 ~ 10 µl ~ 5 µl ~ 2 µl

Analysis Generic extraction with only 7 IS. Internal Standard compensation: Difference in volume extract Variation due to ion suppression Difference in extraction efficiency Difference in desorption efficiency. Selectivity criteria for decision point : Compounds must differentiate from blank by 2 standard deviations Curve should have a R > 0.90.

Results For compounds with their deuterated IS or from the same family (ex : Norcocaine Cocaine-d 3 ), the decision point was established at 25 ng/ml with a R > 0.99.

Results For the other compounds, IS were associated with each compound in order to optimize the detection signal. 2 examples of compounds that have a decision point at 25 ng/ml

Results 122 compounds were analyzed 84 compounds complied with our screening criteria 12 compounds with a decision point of 50 ng/ml 72 compounds with a decision point of 25 ng/ml 8/84 overlap in concentration but differentiate from the blank Data acquired with a LDTD ion source and a Sciex Q-Trap 5500 MS

Observation Challenges: Reproducibility issue, because the pre-wetting (IS), the blood spotting, the extraction and the deposition on a LazWell are all done manually and introduce a precision problem. The fiber can move during manual aspiration of extraction solution. Deposition on the LazWell plate is challenging because of the air gap.

Automation To reduce variability, the extraction process and the deposition/injection can be completely automated.

Automation Calibration curve for Methadone with IS Methadone-d 9. 2.6 Methadone Y = -0.0152852+0.00477128*X R^2 = 0.9962 W: 1/X Area Ratio 2.4 2.2 2.0 1.8 1.6 1.4 1.2 1.0 0.8 0.6 0.4 0.2 0.0 0 50 100 150 200 250 300 350 400 450 500 550 ng/ml LLOQ QC-Low QC-Med QC-High ULQC Nominal conc. (ng/ml) 10 30 150 350 500 N 4 4 4 4 4 Mean (ng/ml) 10.9 29.6 158.0 351.9 477.7 RSD (%) 3.4 3.1 4.1 11.6 2.6 %Nom. conc. 109.4 98.7 105.3 100.5 95.5 Data acquired with a HPLC Shimadzu Nexera X2 TM and a Thermo TSQ Vantage TM MS

Discussion 70% of the compounds were differentiated from the blank with a generic extraction method. Keeping the same extraction method, some compounds could have a lower decision point. Lowering the decision point of the other compounds would require to: use the deuterated IS to enhanced the precision, use an optimized laser pattern to increase the desorption rate, use a specific extraction solution to enhance extraction efficiency.

Conclusion Multiple compounds analyzed with DBS in Tips. Rapid extraction in only 10 seconds. Low volume of blood required (2 µl). Applications in other fields such as pharmacokinetics: Do multiple replicates with the same animal; Use the same animal multiple times; Lower cost.

Acknowledgment The team Pier-Luc Plante Serge Auger Pr. Réal Paquin Pr. Jacques Corbeil Pierre Picard Funding resources CRSNG-FQRNT Mitacs Special thanks for support Phytronix

Questions

Annexe Table of all compounds that were extracted Name IS Cut-off (ng/ml) R MS Mode Name IS Cut-off (ng/ml) R MS Mode 2-OH-Ethylflurazepam Alprazolam-d5 25 0.989 Positif Cocaethylene Cocaine-d3 25 0.996 Positif 4-Methylephedrine Cotinine-d3 25 0.948 Positif Cocaine Cocaine-d3 25 0.994 Positif 5-Fluoro-ABD BZE-d3 25 0.992 Positif Codeine Methadone-d9 25 0.971 Positif 7-Aminoclonazepam Alprazolam-d5 25 0.992 Positif Cotinine Cotinine-d3 25 0.993 Positif 7-Aminoflunitrazepam Alprazolam-d5 25 0.975 Positif Cyclobenzaprine Methadone-d9 25 0.995 Positif Alpha-OH-Alprazalom Alprazolam-d5 25 0.976 Positif Desipramine Cotinine-d3 50 0.931 Positif Alpha-OH-Midazolam BZE-d3 25 0.984 Positif Dextromethorphan No IS 25 0.986 Positif Alpha-Triazolam Alprazolam-d5 25 0.989 Positif Dextrorphan No IS 25 0.982 Positif Alprazalom Alprazolam-d5 25 0.988 Positif Diazepam BZE-d3 25 0.987 Positif Amitriptyline Methadone-d9 50 0.978 Positif Doxepin Methadone-d9 50 0.971 Positif Amobarbital Phenobarbital-d5 50 0.938 Négatif Duloxetine Methadone-d9 25 0.984 Positif Benzoylecgonine BZE-d3 25 0.995 Positif EDDP Cotinine-d3 25 0.987 Positif Butabarbital No IS 25 0.901 Négatif Fentanyl Methadone-d9 25 0.994 Positif Butalbital Phenobarbital-d5 25 0.982 Négatif Flunitrazepam Methadone-d9 25 0.990 Positif Butylone Cotinine-d3 25 0.991 Positif Fluoxetine Cotinine-d3 50 0.983 Positif Carisoprodol No IS 25 0.989 Positif Flurazepam Methadone-d9 25 0.986 Positif Chlorodiazepoxide Alprazolam-d5 25 0.992 Positif Haloperidol Methadone-d9 50 0.951 Positif Citalopram Methadone-d9 25 0.991 Positif Hydroxybuprion Cotinine-d3 25 0.986 Positif Clomipramine Methadone-d9 25 0.994 Positif Imipramine Methadone-d9 25 0.980 Positif Clonazepam Oxazepam-d5 25 0.983 Positif JHW-018-OH Alprazolam-d5 25 0.986 Positif Clozapine Methadone-d9 25 0.986 Positif JHW-073-OH Alprazolam-d5 25 0.994 Positif

Annexe Table of all compounds that were extracted Name IS Cut-off (ng/ml) R MS Mode Name IS Cut-off (ng/ml) R MS Mode Ketamine Cotinine-d3 25 0.925 Positif Nordiazepam BZE-d3 50 0.970 Positif Levitracetam Cotinine-d3 25 0.994 Positif Norfentanyl Methadone-d9 25 0.994 Positif Lorazepam BZE-d3 25 0.953 Positif Norhydrocodone BZE-d3 25 0.989 Positif MDA Cotinine-d3 25 0.976 Positif Norperidine Methadone-d9 25 0.991 Positif MDEA Cotinine-d3 25 0.993 Positif Norquetiapine No IS 25 0.979 Positif MDMA Cotinine-d3 25 0.995 Positif Nortriptyline Methadone-d9 25 0.985 Positif MDPV Methadone-d9 50 0.957 Positif O-desmethyltramadol Methadone-d9 25 0.990 Positif Meprobamate Cocaine-d3 25 0.976 Positif O-desmethylvenlafaxine Cocaine-d3 50 0.975 Positif Merperidine Cotinine-d3 25 0.962 Positif Oxymorphone Methadone-d9 25 0.949 Positif Meta-chlorophenylpiperazine Cotinine-d3 25 0.993 Positif PB-22 Alprazolam-d5 25 0.983 Positif Methadone Methadone-d9 25 0.996 Positif Phenobarbital Phenobarbital-d5 25 0.958 Négatif Methylone Cotinine-d3 25 0.997 Positif Propoxyphene No IS 25 0.984 Positif Methylphenidate Cotinine-d3 25 0.986 Positif Quetiapin Methadone-d9 25 0.984 Positif Midazolam Alprazolam-d5 25 0.986 Positif Secobarbital Phenobarbital-d5 25 0.993 Négatif Mirtazapine Cotinine-d3 25 0.974 Positif Termazepam BZE-d3 25 0.987 Positif Naphyrone Methadone-d9 25 0.989 Positif Topiramate Methadone-d9 50 0.953 Positif Naxolone Methadone-d9 50 0.970 Positif Tradamol Cotinine-d3 25 0.993 Positif N-desmethyl citalopram Methadone-d9 25 0.978 Positif Venlafaxine No IS 25 0.978 Positif N-desmethyl mirtazapine Cotinine-d3 25 0.960 Positif XLR-11 4-Hydroxypentyl Alprazolam-d5 25 0.988 Positif N-desmethyl-clozapine Methadone-d9 50 0.989 Positif Zaleplon Alprazolam-d5 25 0.992 Positif Norcocain Cocaine-d3 25 0.996 Positif Zolpiem Methadone-d9 25 0.960 Positif